Global Radioimmunotherapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 81864
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Radioimmunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Radioimmunotherapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Radioimmunotherapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Radioimmunotherapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Non Hodgkin Lymphoma (NHL)

Follicular Lymphoma

Solid Tumors

Breast Cancer

Ovarian Cancer

Osteosarcoma

Neuroblastoma

Prostate Cancer

Market segment by Application, can be divided into

Tumor Antigens

Radionuclides

Antibodies

Market segment by players, this report covers

Bayer Healthcare Pharmaceuticals

BioSynthema

Clarity Pharmaceuticals

Curasight

Endocyte

Immunomedics

Molecular Insight Pharmaceuticals

Nordic Nanovector

PDL Biopharma

Philogen

RadioMedix

Stella Pharma

Telix Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Radioimmunotherapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Radioimmunotherapy, with revenue, gross margin and global market share of Radioimmunotherapy from 2019 to 2021.

Chapter 3, the Radioimmunotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Radioimmunotherapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Radioimmunotherapy research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Radioimmunotherapy

1.2 Classification of Radioimmunotherapy by Type

1.2.1 Overview: Global Radioimmunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Radioimmunotherapy Revenue Market Share by Type in 2020

1.2.3 Non Hodgkin Lymphoma (NHL)

1.2.4 Follicular Lymphoma

1.2.5 Solid Tumors

1.2.6 Breast Cancer

1.2.7 Ovarian Cancer

1.2.8 Osteosarcoma

1.2.9 Neuroblastoma

1.2.10 Prostate Cancer

1.3 Global Radioimmunotherapy Market by Application

1.3.1 Overview: Global Radioimmunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Tumor Antigens

1.3.3 Radionuclides

1.3.4 Antibodies

1.4 Global Radioimmunotherapy Market Size & Forecast

1.5 Global Radioimmunotherapy Market Size and Forecast by Region

1.5.1 Global Radioimmunotherapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Radioimmunotherapy Market Size by Region, (2016-2021)

1.5.3 North America Radioimmunotherapy Market Size and Prospect (2016-2026)

1.5.4 Europe Radioimmunotherapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Radioimmunotherapy Market Size and Prospect (2016-2026)

1.5.6 South America Radioimmunotherapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Radioimmunotherapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Radioimmunotherapy Market Drivers

1.6.2 Radioimmunotherapy Market Restraints

1.6.3 Radioimmunotherapy Trends Analysis

2 Company Profiles

2.1 Bayer Healthcare Pharmaceuticals

2.1.1 Bayer Healthcare Pharmaceuticals Details

2.1.2 Bayer Healthcare Pharmaceuticals Major Business

2.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product and Solutions

2.1.4 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Bayer Healthcare Pharmaceuticals Recent Developments and Future Plans

2.2 BioSynthema

2.2.1 BioSynthema Details

2.2.2 BioSynthema Major Business

2.2.3 BioSynthema Radioimmunotherapy Product and Solutions

2.2.4 BioSynthema Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 BioSynthema Recent Developments and Future Plans

2.3 Clarity Pharmaceuticals

2.3.1 Clarity Pharmaceuticals Details

2.3.2 Clarity Pharmaceuticals Major Business

2.3.3 Clarity Pharmaceuticals Radioimmunotherapy Product and Solutions

2.3.4 Clarity Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Clarity Pharmaceuticals Recent Developments and Future Plans

2.4 Curasight

2.4.1 Curasight Details

2.4.2 Curasight Major Business

2.4.3 Curasight Radioimmunotherapy Product and Solutions

2.4.4 Curasight Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Curasight Recent Developments and Future Plans

2.5 Endocyte

2.5.1 Endocyte Details

2.5.2 Endocyte Major Business

2.5.3 Endocyte Radioimmunotherapy Product and Solutions

2.5.4 Endocyte Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Endocyte Recent Developments and Future Plans

2.6 Immunomedics

2.6.1 Immunomedics Details

2.6.2 Immunomedics Major Business

2.6.3 Immunomedics Radioimmunotherapy Product and Solutions

2.6.4 Immunomedics Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Immunomedics Recent Developments and Future Plans

2.7 Molecular Insight Pharmaceuticals

2.7.1 Molecular Insight Pharmaceuticals Details

2.7.2 Molecular Insight Pharmaceuticals Major Business

2.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Product and Solutions

2.7.4 Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Molecular Insight Pharmaceuticals Recent Developments and Future Plans

2.8 Nordic Nanovector

2.8.1 Nordic Nanovector Details

2.8.2 Nordic Nanovector Major Business

2.8.3 Nordic Nanovector Radioimmunotherapy Product and Solutions

2.8.4 Nordic Nanovector Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Nordic Nanovector Recent Developments and Future Plans

2.9 PDL Biopharma

2.9.1 PDL Biopharma Details

2.9.2 PDL Biopharma Major Business

2.9.3 PDL Biopharma Radioimmunotherapy Product and Solutions

2.9.4 PDL Biopharma Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 PDL Biopharma Recent Developments and Future Plans

2.10 Philogen

2.10.1 Philogen Details

2.10.2 Philogen Major Business

2.10.3 Philogen Radioimmunotherapy Product and Solutions

2.10.4 Philogen Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Philogen Recent Developments and Future Plans

2.11 RadioMedix

2.11.1 RadioMedix Details

2.11.2 RadioMedix Major Business

2.11.3 RadioMedix Radioimmunotherapy Product and Solutions

2.11.4 RadioMedix Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 RadioMedix Recent Developments and Future Plans

2.12 Stella Pharma

2.12.1 Stella Pharma Details

2.12.2 Stella Pharma Major Business

2.12.3 Stella Pharma Radioimmunotherapy Product and Solutions

2.12.4 Stella Pharma Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Stella Pharma Recent Developments and Future Plans

2.13 Telix Pharmaceuticals

2.13.1 Telix Pharmaceuticals Details

2.13.2 Telix Pharmaceuticals Major Business

2.13.3 Telix Pharmaceuticals Radioimmunotherapy Product and Solutions

2.13.4 Telix Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Telix Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Radioimmunotherapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Radioimmunotherapy Players Market Share

3.2.2 Top 10 Radioimmunotherapy Players Market Share

3.2.3 Market Competition Trend

3.3 Radioimmunotherapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Radioimmunotherapy Revenue and Market Share by Type (2016-2021)

4.2 Global Radioimmunotherapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Radioimmunotherapy Revenue Market Share by Application (2016-2021)

5.2 Radioimmunotherapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Radioimmunotherapy Revenue by Type (2016-2026)

6.2 North America Radioimmunotherapy Revenue by Application (2016-2026)

6.3 North America Radioimmunotherapy Market Size by Country

6.3.1 North America Radioimmunotherapy Revenue by Country (2016-2026)

6.3.2 United States Radioimmunotherapy Market Size and Forecast (2016-2026)

6.3.3 Canada Radioimmunotherapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Radioimmunotherapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Radioimmunotherapy Revenue by Type (2016-2026)

7.2 Europe Radioimmunotherapy Revenue by Application (2016-2026)

7.3 Europe Radioimmunotherapy Market Size by Country

7.3.1 Europe Radioimmunotherapy Revenue by Country (2016-2026)

7.3.2 Germany Radioimmunotherapy Market Size and Forecast (2016-2026)

7.3.3 France Radioimmunotherapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Radioimmunotherapy Market Size and Forecast (2016-2026)

7.3.5 Russia Radioimmunotherapy Market Size and Forecast (2016-2026)

7.3.6 Italy Radioimmunotherapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Radioimmunotherapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Radioimmunotherapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Radioimmunotherapy Market Size by Region

8.3.1 Asia-Pacific Radioimmunotherapy Revenue by Region (2016-2026)

8.3.2 China Radioimmunotherapy Market Size and Forecast (2016-2026)

8.3.3 Japan Radioimmunotherapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Radioimmunotherapy Market Size and Forecast (2016-2026)

8.3.5 India Radioimmunotherapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Radioimmunotherapy Market Size and Forecast (2016-2026)

8.3.7 Australia Radioimmunotherapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Radioimmunotherapy Revenue by Type (2016-2026)

9.2 South America Radioimmunotherapy Revenue by Application (2016-2026)

9.3 South America Radioimmunotherapy Market Size by Country

9.3.1 South America Radioimmunotherapy Revenue by Country (2016-2026)

9.3.2 Brazil Radioimmunotherapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Radioimmunotherapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Radioimmunotherapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Radioimmunotherapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Radioimmunotherapy Market Size by Country

10.3.1 Middle East & Africa Radioimmunotherapy Revenue by Country (2016-2026)

10.3.2 Turkey Radioimmunotherapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Radioimmunotherapy Market Size and Forecast (2016-2026)

10.3.4 UAE Radioimmunotherapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Radioimmunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Radioimmunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Radioimmunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Radioimmunotherapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Radioimmunotherapy Revenue Market Share by Region (2021-2026)

Table 6. Bayer Healthcare Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Bayer Healthcare Pharmaceuticals Major Business

Table 8. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product and Solutions

Table 9. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. BioSynthema Corporate Information, Head Office, and Major Competitors

Table 11. BioSynthema Major Business

Table 12. BioSynthema Radioimmunotherapy Product and Solutions

Table 13. BioSynthema Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Clarity Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 15. Clarity Pharmaceuticals Major Business

Table 16. Clarity Pharmaceuticals Radioimmunotherapy Product and Solutions

Table 17. Clarity Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Curasight Corporate Information, Head Office, and Major Competitors

Table 19. Curasight Major Business

Table 20. Curasight Radioimmunotherapy Product and Solutions

Table 21. Curasight Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Endocyte Corporate Information, Head Office, and Major Competitors

Table 23. Endocyte Major Business

Table 24. Endocyte Radioimmunotherapy Product and Solutions

Table 25. Endocyte Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Immunomedics Corporate Information, Head Office, and Major Competitors

Table 27. Immunomedics Major Business

Table 28. Immunomedics Radioimmunotherapy Product and Solutions

Table 29. Immunomedics Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Molecular Insight Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 31. Molecular Insight Pharmaceuticals Major Business

Table 32. Molecular Insight Pharmaceuticals Radioimmunotherapy Product and Solutions

Table 33. Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Nordic Nanovector Corporate Information, Head Office, and Major Competitors

Table 35. Nordic Nanovector Major Business

Table 36. Nordic Nanovector Radioimmunotherapy Product and Solutions

Table 37. Nordic Nanovector Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. PDL Biopharma Corporate Information, Head Office, and Major Competitors

Table 39. PDL Biopharma Major Business

Table 40. PDL Biopharma Radioimmunotherapy Product and Solutions

Table 41. PDL Biopharma Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Philogen Corporate Information, Head Office, and Major Competitors

Table 43. Philogen Major Business

Table 44. Philogen Radioimmunotherapy Product and Solutions

Table 45. Philogen Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. RadioMedix Corporate Information, Head Office, and Major Competitors

Table 47. RadioMedix Major Business

Table 48. RadioMedix Radioimmunotherapy Product and Solutions

Table 49. RadioMedix Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Stella Pharma Corporate Information, Head Office, and Major Competitors

Table 51. Stella Pharma Major Business

Table 52. Stella Pharma Radioimmunotherapy Product and Solutions

Table 53. Stella Pharma Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Telix Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. Telix Pharmaceuticals Major Business

Table 56. Telix Pharmaceuticals Radioimmunotherapy Product and Solutions

Table 57. Telix Pharmaceuticals Radioimmunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global Radioimmunotherapy Revenue (USD Million) by Players (2019-2021)

Table 59. Global Radioimmunotherapy Revenue Share by Players (2019-2021)

Table 60. Breakdown of Radioimmunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Radioimmunotherapy Players Head Office, Products and Services Provided

Table 62. Radioimmunotherapy Mergers & Acquisitions in the Past Five Years

Table 63. Radioimmunotherapy New Entrants and Expansion Plans

Table 64. Global Radioimmunotherapy Revenue (USD Million) by Type (2016-2021)

Table 65. Global Radioimmunotherapy Revenue Share by Type (2016-2021)

Table 66. Global Radioimmunotherapy Revenue Forecast by Type (2021-2026)

Table 67. Global Radioimmunotherapy Revenue by Application (2016-2021)

Table 68. Global Radioimmunotherapy Revenue Forecast by Application (2021-2026)

Table 69. North America Radioimmunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 70. North America Radioimmunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 71. North America Radioimmunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 72. North America Radioimmunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 73. North America Radioimmunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 74. North America Radioimmunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 75. Europe Radioimmunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 76. Europe Radioimmunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 77. Europe Radioimmunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 78. Europe Radioimmunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 79. Europe Radioimmunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 80. Europe Radioimmunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 81. Asia-Pacific Radioimmunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 82. Asia-Pacific Radioimmunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 83. Asia-Pacific Radioimmunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 84. Asia-Pacific Radioimmunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 85. Asia-Pacific Radioimmunotherapy Revenue by Region (2016-2021) & (USD Million)

Table 86. Asia-Pacific Radioimmunotherapy Revenue by Region (2021-2026) & (USD Million)

Table 87. South America Radioimmunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 88. South America Radioimmunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 89. South America Radioimmunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 90. South America Radioimmunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 91. South America Radioimmunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 92. South America Radioimmunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 93. Middle East & Africa Radioimmunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 94. Middle East & Africa Radioimmunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 95. Middle East & Africa Radioimmunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 96. Middle East & Africa Radioimmunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 97. Middle East & Africa Radioimmunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 98. Middle East & Africa Radioimmunotherapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Radioimmunotherapy Picture

Figure 2. Global Radioimmunotherapy Revenue Market Share by Type in 2020

Figure 3. Non Hodgkin Lymphoma (NHL)

Figure 4. Follicular Lymphoma

Figure 5. Solid Tumors

Figure 6. Breast Cancer

Figure 7. Ovarian Cancer

Figure 8. Osteosarcoma

Figure 9. Neuroblastoma

Figure 10. Prostate Cancer

Figure 11. Radioimmunotherapy Revenue Market Share by Application in 2020

Figure 12. Tumor Antigens Picture

Figure 13. Radionuclides Picture

Figure 14. Antibodies Picture

Figure 15. Global Radioimmunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global Radioimmunotherapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global Radioimmunotherapy Revenue Market Share by Region (2016-2026)

Figure 18. Global Radioimmunotherapy Revenue Market Share by Region in 2020

Figure 19. North America Radioimmunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe Radioimmunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific Radioimmunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America Radioimmunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Middle East and Africa Radioimmunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Radioimmunotherapy Market Drivers

Figure 25. Radioimmunotherapy Market Restraints

Figure 26. Radioimmunotherapy Market Trends

Figure 27. Bayer Healthcare Pharmaceuticals Recent Developments and Future Plans

Figure 28. BioSynthema Recent Developments and Future Plans

Figure 29. Clarity Pharmaceuticals Recent Developments and Future Plans

Figure 30. Curasight Recent Developments and Future Plans

Figure 31. Endocyte Recent Developments and Future Plans

Figure 32. Immunomedics Recent Developments and Future Plans

Figure 33. Molecular Insight Pharmaceuticals Recent Developments and Future Plans

Figure 34. Nordic Nanovector Recent Developments and Future Plans

Figure 35. PDL Biopharma Recent Developments and Future Plans

Figure 36. Philogen Recent Developments and Future Plans

Figure 37. RadioMedix Recent Developments and Future Plans

Figure 38. Stella Pharma Recent Developments and Future Plans

Figure 39. Telix Pharmaceuticals Recent Developments and Future Plans

Figure 40. Global Radioimmunotherapy Revenue Share by Players in 2020

Figure 41. Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 42. Global Top 3 Players Radioimmunotherapy Revenue Market Share in 2020

Figure 43. Global Top 10 Players Radioimmunotherapy Revenue Market Share in 2020

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 45. Global Radioimmunotherapy Revenue Share by Type in 2020

Figure 46. Global Radioimmunotherapy Market Share Forecast by Type (2021-2026)

Figure 47. Global Radioimmunotherapy Revenue Share by Application in 2020

Figure 48. Global Radioimmunotherapy Market Share Forecast by Application (2021-2026)

Figure 49. North America Radioimmunotherapy Sales Market Share by Type (2016-2026)

Figure 50. North America Radioimmunotherapy Sales Market Share by Application (2016-2026)

Figure 51. North America Radioimmunotherapy Revenue Market Share by Country (2016-2026)

Figure 52. United States Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Canada Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Mexico Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Europe Radioimmunotherapy Sales Market Share by Type (2016-2026)

Figure 56. Europe Radioimmunotherapy Sales Market Share by Application (2016-2026)

Figure 57. Europe Radioimmunotherapy Revenue Market Share by Country (2016-2026)

Figure 58. Germany Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. France Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. United Kingdom Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Russia Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Italy Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Asia-Pacific Radioimmunotherapy Sales Market Share by Type (2016-2026)

Figure 64. Asia-Pacific Radioimmunotherapy Sales Market Share by Application (2016-2026)

Figure 65. Asia-Pacific Radioimmunotherapy Revenue Market Share by Region (2016-2026)

Figure 66. China Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Japan Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South Korea Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. India Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Southeast Asia Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Australia Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. South America Radioimmunotherapy Sales Market Share by Type (2016-2026)

Figure 73. South America Radioimmunotherapy Sales Market Share by Application (2016-2026)

Figure 74. South America Radioimmunotherapy Revenue Market Share by Country (2016-2026)

Figure 75. Brazil Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Argentina Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Middle East and Africa Radioimmunotherapy Sales Market Share by Type (2016-2026)

Figure 78. Middle East and Africa Radioimmunotherapy Sales Market Share by Application (2016-2026)

Figure 79. Middle East and Africa Radioimmunotherapy Revenue Market Share by Country (2016-2026)

Figure 80. Turkey Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Saudi Arabia Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. UAE Radioimmunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz